At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
XprESS device and PathAssist confirmation toolsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
XprESS Device and PathAssist Confirmation Tools in Pediatric Patients-Expanded Indication Study
In Brief
A clinical study evaluating XprESS device and PathAssist confirmation tools for Sinusitis. Completed, enrolled 50 participants across 4 sites.
Detailed Summary
Safety and effectiveness of sinus balloon dilation in patients 2-21 years old.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSinusitis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
First PostedOct 2014
Primary CompletionSep 2015
Study CompletionJan 2016
TodayJul 2026
First PostedOct 30, 2014
Enrollment StartSep 1, 2014
Primary CompletionSep 1, 2015
Study CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.7 years ago
Interventions
XprESS device and PathAssist confirmation toolsdevice